Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

David Ruggiero Join Sinch as Senior Vice President of Sales

Appointment Aims to Drive Growth and Strengthen Customer Relationships in North AmericaATLANTA, Georgia and STOCKHOLM, Sweden – November 11, 2024 – Sinch  (Sinch AB (publ) – XSTO: SINCH), which is pioneering the way the world communicates through its Customer Communications Cloud, is pleased to announce the appointment of David Ruggiero as Senior Vice President of Sales for the North America region.  A highly experienced executive with over 25 years of expertise in sales leadership across Enterprise, Mid Markets and SMB, David will lead Sinch’s sales strategy in the

Telia Towers Norway chooses iLOQ smart locks to enhance security

iLOQ has signed a ground-breaking agreement with Telia Towers Norway for the deployment of its innovative battery-free and keyless smart-locking system across the company’s more than 1000 tower sites. The rollout of iLOQ’s advanced locking system has already commenced, with a goal to replace Telia Towers’ existing locks throughout their footprint in Norway over the next two years. The existing locks can be quickly and easily replaced with iLOQ’s smart locks with no changes to the existing infrastructure needed. iLOQ’s technology will enhance both convenience and security by

Cary Group strengthens the management team

Cary Group, a European market leader in vehicle glass repair and replacement, has appointed Lars Egelstig as new CFO. At the same time, Joakim Rasiwala, the company's current CFO, will transfer to the role as Head of M&A and Integration.Lars Egelstig, who takes up his role as CFO of Cary Group today, November 11th, comes most recently from the role of CFO at Nordomatic. Joakim Rasiwala, current CFO at Cary Group, will gradually transition to the new role of Head of M&A and Integration during the remainder of 2024. The role means that Joakim will be responsible for Cary Group's Mergers &

SSAB at COP29: Time to commit to ambitious climate plans to drive the transition forward

SSAB is joining Business Sweden’s delegation to the United Nations Climate Change Conference, COP29 in Baku, Azerbaijan. Our hope is that countries increase their national ambitions to limit climate change and to create enabling conditions for investments and a competitive transformation. SSAB will describe our journey to near zero-emission steelmaking as a way of exemplifying what breakthrough technologies are available to decarbonize the steel industry. Last year’s COP marked a moment of progress as the need to transition away from fossil fuels was mentioned for the first time

Celebrating excellence in emerging markets: East Capital Awards 2024 honours Optima Bank, Gravita, FPT Corporation, and Qifu Technology

For over two decades, East Capital has celebrated companies within its investment portfolio that drive positive change. The prestigious East Capital Awards highlight those organizations that stand out for their growth, governance, and pioneering achievements. In 2024, the Awards reflect the remarkable geographical spread and strength of East Capital’s emerging market’s universe, spanning Greece, India, Vietnam, and China. We are proud to announce this year’s winners across four categories: Best IPO, Discovery of the Year, Best Growth, and Best Corporate Governance.· Optima Bank – Best IPO

Oncoinvent Announces Promising Interim Results for Radspherin® as a Potential Treatment for Peritoneal Carcinomatoses

Oncoinvent ASA, a clinical stage company advancing alpha emitter therapy across a variety of solid cancers, today announced an interim data readout of the Phase 1/2a studies of Radspherin® for the treatment of peritoneal carcinomatoses. The studies were closed for recruitment at the end of 2023, and patients are currently in long-term follow-up. The readout confirmed the previously published results on efficacy and adds further confidence in the ongoing randomized controlled Phase 2 clinical trial for Radspherin® in patients with ovarian cancer.In the first interim readout from the Phase 1

Episurf Medical to present at Redeye Medtech & Diagnostics Event on November 13th, 2024

Episurf Medical (Nasdaq: EPIS B) will attend Redeye Medtech & Diagnostics Event which is held on November 13th, 2024. The event is arranged by Redeye and the company will be represented by its CEO Pål Ryfors. The format will be a 12-minute presentation followed by an 8-minute Q&A Session. The presentation will be streamed live at 09:50 CET at https://www.redeye.se/events/1016182/redeye-theme-medtech-diagnostics-3 and will also be made available afterwards on our website www.episurf.com. If you would like to attend the event in person, you can register at https://crm.redeye.se/events/

Interim report Q3, 2024

Third quarter · Net sales amounted to SEK 1.9 (3.9*) million · EBITDA amounted to SEK -1.8 (-2.2) million · EBIT amounted to SEK -8.5 (-18.0) million · EBT amounted to SEK -10.3 (-18.8) million - Change of Certified Adviser (CA) to Bergs Securities *including revenues from the now divested company BizWell Sweden AB  Dear Valued Shareholders, I hope this message finds you well. As we reflect on the third quarter, it’s important to acknowledge that our financial results fell short of expectations, especially compared to the same period last year. Despite these

TF Bank: Monthly statistics October 2024

The total loan portfolio amounted to SEK 21,159 million at the end of October. Compared to October 2023, the loan portfolio has increased by 20 % in local currencies.  Month Oct-24 Oct-23 ChangeCredit Cards   New lending, SEK million 1,560 1,051 48 %Ecommerce Solutions   Transaction volume*, SEK million 1,290 1,386 -7 %Consumer Lending   New lending, SEK million 476 279 71 %  Cumulative for the year Jan-Oct 24 Jan-Oct 23 ChangeCredit Cards   New lending, SEK million 13,

Finnish Nurminen Logistics Plc acquires Swedish railway logistics company Essinge Rail AB and grows into a significant Nordic railway operator

Nurminen Logistics Plc      Press release 11 November 2024 at 9.15 a.m. EET  Finnish logistics company, Nurminen Logistics Plc, acquires the Swedish railway logistics company Essinge Rail AB. With the acquisition, Nurminen Logistics will grow into a significant railway operator in the growing freight traffic between the Nordic countries and Continental Europe, serving Nordic and international companies in the industrial, technology and commercial sectors. The acquisition is part of Nurminen Logistics' profitable internationalization and growth strategy, which significantly expands the

Suomen Lantakaasu investing more than EUR 80 million in Kiuruvesi biogas plant project

Suomen Lantakaasu Oy’s biogas plant to be constructed in Kiuruvesi, Finland will produce renewable liquefied biogas from cattle farm manure in Upper Savo and from other agricultural and food industry byproducts. The investment covers the construction of the biogas plant and the liquefaction unit. The preparatory groundwork phase has already been finalized and construction of the biogas plant will begin this winter. The plant will be completed in 2026.The Kiuruvesi biogas plant is part of the Upper Savo complex that includes the industrial-scale, centralised liquefied biogas production plant

Inside information: Nurminen Logistics Plc acquires Swedish railway logistics company Essinge Rail AB and grows in rail logistics between the Nordic countries and Continental Europe

Nurminen Logistics Plc    Stock Exchange Release (Inside information)     11 November 2024 at 09.00 a.m. EET  Nurminen Logistics Plc has signed an agreement to acquire the entire share capital of the Swedish Essinge Rail AB. With the acquisition, Nurminen Logistics Plc will become a significant railway operator in the growing freight traffic between the Nordic countries and Continental Europe, serving Nordic and international companies in the industrial, technology and commercial sectors. The acquisition is part of Nurminen Logistics' international growth strategy, which focuses on

The subscription period in Spermosens’ rights issue of units begins today

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE   Today, 11 November 2024, is the first day of the subscription period in Spermosens AB:s (publ) (“Spermosens” or the “Company”) issue of a maximum of 283,607,120 units, corresponding to a maximum of 2,268,856,960 shares,

Nomination Committee appointed for Bactiguard Holding AB’s Annual General Meeting 2025

The Nomination Committee for the Annual General Meeting of Bactiguard Holding AB (publ), to be held on Thursday 15 May 2025 in Stockholm, has been appointed. The Nomination Committee will consist of: · Helena Borglund (appointed by TomBact AB) · Christian Kinch (appointed by GIDL Invest AB) · Jan Ståhlberg (appointed by Jan Ståhlberg) · Mats J Andersson (appointed by Nordea Fonder) · Jannis Kitsakis (appointed by Fjärde AP Fonden) In accordance with the instructions for the Nomination Committee in Bactiguard Holding AB (publ), the Nomination Committee shall consist of

Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)

The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Extraordinary General Meeting (the “Meeting”), to be held on Wednesday, 11 December 2024 at 09.00 at the offices of Mannheimer Swartling Advokatbyrå, Norrlandsgatan 21, Stockholm, Sweden. Registration for the Meeting will begin at 08.30.The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the Meeting also by postal voting.   Right to participate and registration (A) Participation at the meeting venue A person who wishes

Norbert Hanke appointed interim President and CEO of Hexagon AB

The Board of Directors of Hexagon AB and Paolo Guglielmini have mutually agreed that Paolo will step down from his position as Hexagon’s President and CEO. The Board sees a new leadership approach as essential to steer the company through its next phase. The Board of Directors of Hexagon AB has appointed Norbert Hanke as interim President and Chief Executive Officer of Hexagon AB. Norbert Hanke assumes his position with immediate effect. Norbert joined Hexagon in 2001, most recently serving as Hexagon’s COO (Chief Operating Officer) and prior to that as Hexagon’s Manufacturing

Diagonal Bio announces that it is exploring financing options

Diagonal Bio AB ("Diagonal Bio" or "the Company") today announces that the Board of Directors of the Company has engaged financial and legal advisors and decided to explore potential financing alternatives to secure the Company’s ongoing operations and support its strategic goals. The current funds last until mid-February 2025.Diagonal Bio is in discussions with strategic investors and several of its larger shareholders regarding possible solutions to address the Company’s liquidity situation. In addition, the Company has engaged a financial advisor as well as a legal advisor to assist in

Read original

Everfuel A/S - Notice of extraordinary general meeting

Herning, Denmark, 11 November 2024 - In compliance with Everfuel A/S' (the "Company" or "Everfuel") obligations pursuant to the transaction agreement entered into with Faro BidCo ApS (the "Offeror") on 28 August 2024, and in anticipation of the Offeror acquiring at least approximately 90.5% of the issued and outstanding share capital and voting rights of the Company on a Fully Diluted basis (as defined in the offer document related to the unregulated recommended voluntary cash offer published on 2 September 2024; the "Offer Document"), and the shares of the Company ultimately becoming

Directorate Changes

11 November 2024 LSE: PDL   Petra Diamonds Limited ("Petra” or "the Company")   Directorate Changes   Petra announces that Varda Shine has notified the Company that she will not offer herself for re-election at the Company’s forthcoming Annual General Meeting on 13 November 2024 and will retire from the Board at the conclusion of that meeting.   Varda Shine said:   “I am stepping down from the Board for personal reasons, having indicated last year that I will take on the role of Chair of Petra only for a short period. It has been an honour and a

Targeting Soluble Clever-1 for Autoimmune Diseases

Faron Pharmaceuticals Ltd.   (“Faron” or “the Company”)    Pipeline Update: Targeting Soluble Clever-1 for Autoimmune Diseases   Press release, 11 November 2024   TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers and inflammation via novel immunotherapies, today announces the filing of a patent application around the use of soluble Clever-1 for inactivating T-cells and the treatment of autoimmune diseases and inflammatory disorders. The related manuscript can be read

CS MEDICA Expands Presence in Eastern Europe through New Partnership

CANNORDIC, the subsidiary of CS MEDICA, secures an exclusive deal with Deutsch-Pharm in Ukraine, signaling a sales potential of DKK 750.000.CS MEDICA announces that its subsidiary, CANNORDIC, has established a white-label partnership with Deutsch-Pharm, a top pharmaceutical distributor in Ukraine. This deal is subject to successful product registration with Ukrainian health authorities and includes a 100% prepayment from Deutsch-Pharm upon registration approval, expected within a 1–2-month timeframe. The selected skin duo, comprising the Psoriasis Gel and Skin Relief Lotion, offers a

Sivers Semiconductors AB (publ), publishes Interim Report Q3, January – September 2024

Kista, Sweden // 11 November 2024 // Sivers Semiconductors AB (STO: SIVE), a leading supplier of RF beamformers for Satellite Communications (SATCOM) and Photonics lasers for AI Datacenters, today announced its Q3 2024 results, highlighting its role in addressing two critical secular trends: AI acceleration and mmWave adoption. With a focus on advanced photonics and wireless technologies, Sivers continues to drive innovation in these high-performance, energy-efficient sectors.Financial Highlights: · Q3 2024 revenue totaled SEK 58.7 m, up from SEK 58.3 m in Q3 2023, reflecting a 4%

There are no items matching the current filter
There are no more items matching the current filter
Back to top